BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM
168 results:

  • 1. Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
    Mehra T; Lupatsch JE; Kössler T; Dedes K; Siebenhüner AR; von Moos R; Wicki A; Schwenkglenks ME
    PLoS One; 2024; 19(4):e0301271. PubMed ID: 38573891
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.
    Bae SJ; Kim HJ; Kim HA; Ryu JM; Park S; Lee EG; Im SA; Jung Y; Park MH; Park KH; Kang SH; Park E; Kim SY; Lee MH; Kim LS; Lee A; Noh WC; Gwark S; Kim S; Jeong J
    Int J Surg; 2024 Feb; 110(2):934-942. PubMed ID: 38000057
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of plasma branched-chain amino acid with multiple cancers: A mendelian randomization analysis.
    Xu H; Wang X; Xu X; Liu L; Zhang Y; Yan X; Zhang Y; Dang K; Li Y
    Clin Nutr; 2023 Dec; 42(12):2493-2502. PubMed ID: 37922693
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A 16-year bicentric retrospective analysis of ovarian tissue cryopreservation in pediatric units: indications, results, and outcome.
    Grellet-Grün M; Delepine B; Le Van Quyen P; Avérous G; Durlach A; Greze C; Ladureau-Fritsch L; Lichtblau I; Canepa AS; Liné A; Paillard C; Pluchart C; Pirrello O; Rongieres C; Harika G; Becmeur F; Teletin M
    Front Endocrinol (Lausanne); 2023; 14():1158405. PubMed ID: 37720539
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Thoracic epidural analgesia as part of an enhanced recovery program in gynecologic oncology: a prospective cohort study.
    Pandraklakis A; Haidopoulos D; Lappas T; Stamatakis E; Valsamidis D; Oikonomou MD; Loutradis D; Rodolakis A; Bisch SP; Nelson G; Thomakos N
    Int J Gynecol Cancer; 2023 Nov; 33(11):1794-1799. PubMed ID: 37652530
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.
    Wilcox N; Dumont M; González-Neira A; Carvalho S; Joly Beauparlant C; Crotti M; Luccarini C; Soucy P; Dubois S; Nuñez-Torres R; Pita G; Gardner EJ; Dennis J; Alonso MR; Álvarez N; Baynes C; Collin-Deschesnes AC; Desjardins S; Becher H; Behrens S; Bolla MK; Castelao JE; Chang-Claude J; Cornelissen S; Dörk T; Engel C; Gago-Dominguez M; Guénel P; Hadjisavvas A; Hahnen E; Hartman M; Herráez B; ; Jung A; Keeman R; Kiechle M; Li J; Loizidou MA; Lush M; Michailidou K; Panayiotidis MI; Sim X; Teo SH; Tyrer JP; van der Kolk LE; Wahlström C; Wang Q; Perry JRB; Benitez J; Schmidt MK; Schmutzler RK; Pharoah PDP; Droit A; Dunning AM; Kvist A; Devilee P; Easton DF; Simard J
    Nat Genet; 2023 Sep; 55(9):1435-1439. PubMed ID: 37592023
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors.
    McGonigal S; Wu R; Grimley E; Turk EG; Zhai Y; Cho KR; Buckanovich RJ
    Gynecol Oncol; 2023 Sep; 176():139-146. PubMed ID: 37535994
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Borella F; Bertero L; Valabrega G; Fucina S; Cassoni P; Benedetto C
    Int J Gynaecol Obstet; 2024 Jan; 164(1):262-269. PubMed ID: 37496460
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids.
    Thao V; Moriarty JP; Stewart EA; Borah BJ
    J Minim Invasive Gynecol; 2023 Oct; 30(10):813-819. PubMed ID: 37286130
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Radiotherapy in recurrent ovarian cancer: updated results of involved-field radiation therapy.
    Lee BM; Lee SJ; Kim N; Byun HK; Kim YB
    Int J Gynecol Cancer; 2023 Jul; 33(7):1106-1111. PubMed ID: 37217239
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer.
    Piedimonte S; Kim R; Bernardini MQ; Atenafu EG; Clark M; Lheureux S; May T
    Gynecol Oncol; 2022 Dec; 167(3):417-422. PubMed ID: 37191644
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. LILRB1
    Xu X; Yin S; Wang Y; Zhu Q; Zheng G; Lu Y; Li T; Zhu C
    Int Immunopharmacol; 2023 Jun; 119():110162. PubMed ID: 37075669
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study.
    Yagi K; Maruo A; Ishida S; Aizawa F; Ushio S; Sakaguchi S; Kajizono M; Niimura T; Goda M; Hamano H; Izawa-Ishizawa Y; Zamami Y; Ishizawa K
    Clin Exp Med; 2023 Oct; 23(6):2799-2804. PubMed ID: 36738305
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
    Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
    Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats.
    Louisa M; Wanafri E; Arozal W; Sandhiutami NMD; Basalamah AM
    Pharm Biol; 2023 Dec; 61(1):298-305. PubMed ID: 36708211
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers.
    Alwosaibai K; Aalmri S; Mashhour M; Ghandorah S; Alshangiti A; Azam F; Selwi W; Gharaibeh L; Alatawi Y; Alruwaii Z; Alsaab HO
    BMC Cancer; 2023 Jan; 23(1):13. PubMed ID: 36604635
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Frequency of thoracic recurrence based on pathological features in patients with ovarian epithelial tumors in stage I versus higher stages.
    Matsutani H; Nakai G; Fujiwara S; Takahashi S; Yamamoto K; Ohmichi M; Osuga K
    Jpn J Radiol; 2023 May; 41(5):500-509. PubMed ID: 36575285
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Health-related quality of life in children and adolescents with pleuropulmonary blastoma: A report from the International PPB/DICER1 Registry.
    Nelson AT; Dybvik A; Mallinger P; Weiss McQuaid S; Watson D; Harney LA; Stewart DR; Dehner LP; Messinger YH; Kunin-Batson AS; Schultz KAP
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30077. PubMed ID: 36424733
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Is microcystic, elongated, and fragmented pattern of myometrial invasion in endometrioid endometrial carcinoma associated with survival?
    Altındağ SD; Yiğit S; Şen S
    Turk J Med Sci; 2022 Oct; 52(5):1569-1579. PubMed ID: 36422476
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Lack of impact of the aldh2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
    Mori T; Okamoto Y; Mu A; Ide Y; Yoshimura A; Senda N; Inagaki-Kawata Y; Kawashima M; Kitao H; Tokunaga E; Miyoshi Y; Ohsumi S; Tsugawa K; Ohta T; Katagiri T; Ohtsuru S; Koike K; Ogawa S; Toi M; Iwata H; Nakamura S; Matsuo K; Takata M
    Cancer Med; 2023 Mar; 12(6):6594-6602. PubMed ID: 36345163
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.